TB Clip September 2022 (2) article image

편집자 한마디!

국내외 결핵(TB)뉴스

학술연구자료

STOP-TB한국사무국 소식

26일부터 실외에서의 마스크 의무 착용이 해제되고, 3년 가까이 끌어온 COVID-19이 보건위기에서 엔데믹으로 넘어가고 있습니다. 지난해 WHO의 결핵보고서를 보면, COVID-19으로 결핵 진단을 받은 사람은 580만 명으로 전년도(710만 명)보다 18% 이상 줄었으나, 역으로 계속 줄어만 오던 결핵 사망자의 숫자는 늘어났습니다. 앞으로 COVID-19으로 등한시된 결핵의 진단과 치료에 대한 투자가 필요해 보이는 시점에서 Global Fund가 142억5000만 달러를 모금했다는 반가운 뉴스가 있었습니다. 또한 우리 정부도 2019년의 기부 공약을 4배로 늘린 1억 달러 기부를 약속하였습니다. 하지만 결핵퇴치를 위한 이 기념비적 연대와 한국의 약속이 국내에서 더 알려 지지 못하고, 대통령의 한마디로 파묻혀 아쉬울 따름입니다.

The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) released a report with cumulative results through the end of 2021 in the responses to HIV, TB and malaria, revealing a significant rebound in 2021 for programs working to defeat the three diseases. The impact of COVID-19 on TB programs has been significant: In 2020, the number of deaths from TB rose for the first time. Even though in 2021 COVID-19 remained a challenge, TB programs started to recover.

The 72nd session of the World Health Organization (WHO) Regional Committee for Europe, held on 12–14 September 2022 in Tel Aviv, Israel, endorsed TB action plan for the WHO European Region 2023–2030 , outlining the vision and strategic actions for the region. The Plan is meant to support member states in implementing national TB responses in reaching the targets of the global end TB strategy to reduce TB incidence by 80% and TB deaths by 90% by 2030.

The Stop TB Partnership and hosted a virtual event on 22 September 2022 on the sidelines of the 77th Session of the United Nations General Assembly (UNGA 77) bringing global health leaders together to focus on what’s needed to accelerate progress for ending TB by 2030. For further details about the event and to register, click here.

On 14 September 2022, the Stop TB Partnership's Global Drug Facility communicated that there could be significant supply delays of the critical GeneXpert TB test due to production constraints by Cepheid. 'It is unacceptable that the US corporation Cepheid seems to prioritize selling COVID tests to wealthy countries over supplying high TB burden countries with TB tests... At a time when national programs are seeking to scale up TB testing to at least pre-COVID levels, Cepheid must stop backsliding and prioritizing profits over people’s lives and take urgent measures to ensure this TB test is available and affordable in all countries with a high TB burden.' (Stijn Deborggraeve, Diagnostics Advisor, Médecins Sans Frontières (MSF) Access Campaign)

Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) and the WHO Civil Society Task Force on TB released a joint statement calling for increased political commitment and accountability, and setting collective priorities in preparation for the 2023 UN High-Level Meeting on TB.

The World Health Organization (WHO) released new guidance to support national strategic planning for the TB response. The guidance encourages the use of a people-centeric focus in the development of national TB strategic plan. It highlights the importance of government stewardship and ownership, promotes alignment with national health strategy and other health programs, emphasizes multi-stakeholder and multi-sectoral engagement as one of the key steps for multi-sectoral accountability for TB

Dr Michel Gasana, TB Medical Officer, World Health Organization (WHO) – Regional Office for Africa emphasized that TB was not yet at the forefront of health priorities in countries and engagement required from other development sectors to complement efforts made by the health sector was inadequate.

Treatment Action Group (TAG) is seeking a dynamic, highly motivated, and organized Senior TB Project Associate to support community engagement activities under the SMART4TB Project – a $200 million investment made by the U.S. Agency for International Development (USAID) to Support, Mobilize, and Accelerate Research for TB Elimination. For full details about the position, click here

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced the execution of a joint development agreement supporting the evaluation of five antimicrobial agents across two combination regimens for treating both drug-susceptible and drug-resistant forms of TB with shorter treatment durations. Source: TB Alliance

On September 22, the U.S. Agency for International Development (USAID) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) kicked off in Almaty, Kazakhstan the 6^th International Tuberculosis Conference on “Eliminating Tuberculosis in Central Asia: Best practices, challenges, and perspectives”.

The Joint United Nations Programme on HIV/AIDS (UNAIDS) applauded donors for pledging the largest amount ever to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). Donors pledged US$ 14.25 billion at the Global Fund’s Seventh Replenishment Conference to support efforts to end the three pandemics with more funding set to come.

A study published in Nature Biomedical Engineering presented a new blood test combining nanotechnology with artificial intelligence to diagnose TB in children in instances when the disease might otherwise go undetected.

In a study published in Cell Reports Medicine, researchers used machine learning to design a data-driven solution for a faster, more effective way to identify potential new drug combinations to better treat TB.

An analysis published in JAMA Infectious Diseases found that patients with pulmonary TB were able to improve their quality of life while reducing the monumental costs that come with the disease by utilizing a digital medication event reminder monitor.

A study, published in the Journal of Pharmaceutical Sciences , showed very promising results for the potential treatment of TB using curdlan-based nanoparticles.

A study, published in Cell Reports Medicine , demonstrated the protective potential of multiple doses of the bacillus Calmette-Guerin (BCG) vaccine against COVID-19 and other infectious diseases.

A study, published in BMC: Part of Springer Nature , reviewed aimed to examine the quality, design, implementation challenges, and successes of TB-stigma intervention studies and created a novel conceptual framework of pathways to TB-stigma reduction.

새 창 새 창 새 창 새 창